GSK Investigational Site

Willingboro, New Jersey 08046

0 studies enrolling now · 7 studies all time

What they study most

Depressive Disorder, Healthy Subjects, Hepatitis C, Irritable Bowel Syndrome (IBS), Irritable Colon, Migraine Disorders, Post-Traumatic Stress Disorder

Studies at this site

• A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder — Stopped early
• Orvepitant (GW823296) in Adult Post Traumatic Stress Disorder — Completed
• A First Time in Human Study to Assess the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of Single and Repeat Doses of GSK2485852 in Chronically Infected Hepatitis C Subjects — Stopped early
• A First Time in Human Study to Assess GSK2336805 in Healthy Volunteers and Single Doses in Chronically Infected Hepatitis C Patients. — Completed
• Migraine Study in Adolescent Patients — Completed
• Study In Women With Severe Diarrhea-Predominant Irritable Bowel Syndrome Having Failed Conventional Therapy — Completed
• A Study To Investigate The Metabolism Of GW876008 In Smokers Compared To Non-Smokers. — Completed